Jeffrey S. Bornstein - Director at Kalaris Therapeutics, Inc.

Insider Transactions and Holdings

Identity
Entity type
Individual
Role
Director
Issuer context
Issuer symbol
KLRS on Nasdaq
SEC evidence
Source filings
Open source filing history

There are no Buy or Sell transactions made by Jeffrey S. Bornstein since 31 May 2025

Holdings reported by Jeffrey S. Bornstein for Kalaris Therapeutics, Inc.

Form 4 holding Director

Allovir, Inc.

Security class
Common Stock
Shares / value
110,197
Estimated value
$87,309
Report date
06 Jun 2024
Price
$0.7923
Ownership
Direct

Transactions reported by Jeffrey S. Bornstein for Kalaris Therapeutics, Inc.

Sym Class Transaction % Reported value Reported price Shares Shares after Date Ownership
* indicates a reported price that failed the local validity check.
We use cookies and similar technologies to provide certain features, enhance the user experience and, if you allow them, measure engagement and deliver advertising. Analytics and marketing storage stay off until you grant consent. By clicking on "Agree and continue", you declare your consent to the use of the selected optional cookies. Manage preferences to update or revoke optional consent for future visits. For more information, see our Privacy Policy .